 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Medical News FDA: HIV Drug Lexiva Label to Warn of Cholesterol IncreasesDecember 4, 2009 GlaxoSmithKline PLC has written to doctors regarding label changes in its HIV drug Lexiva. The letter, which the Food and Drug Administration posted on its Web site Thursday, warns of increases in cholesterol levels and discusses a "potential" increase in heart attacks. GSK recommended that doctors check patients' cholesterol and triglyceride levels before and during treatment with Lexiva, and that patients also be monitored for high blood pressure, diabetes, and smoking. To read the letter, click here. wsj.com 12.03.2009; Jennifer Corbett Dooren, Dow Jones Newswires  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
